Methocinnamox is a Potent and Long-Acting Antagonist that can Prevent and Reverse Opioid-Induced Respiratory Depression.
作者信息
Carr James A, Morgan Daniel J
机构信息
Department of Biology, Texas Tech University, Lubbock, Texas (J.A.C.) and Department of Biomedical Sciences, Marshall University, Huntington, West Virginia (D.J.M.).
Department of Biology, Texas Tech University, Lubbock, Texas (J.A.C.) and Department of Biomedical Sciences, Marshall University, Huntington, West Virginia (D.J.M.)
出版信息
J Pharmacol Exp Ther. 2024 Sep 18;391(1):1-3. doi: 10.1124/jpet.124.002205.
Abstract
摘要
相似文献
1
Methocinnamox is a Potent and Long-Acting Antagonist that can Prevent and Reverse Opioid-Induced Respiratory Depression.
J Pharmacol Exp Ther. 2024 Sep 18;391(1):1-3. doi: 10.1124/jpet.124.002205.
2
Comparison of the -Opioid Receptor Antagonists Methocinnamox and Naloxone to Reverse and Prevent the Ventilatory Depressant Effects of Fentanyl, Carfentanil, 3-Methylfentanyl, and Heroin in Male Rats.
J Pharmacol Exp Ther. 2024 Sep 18;391(1):4-17. doi: 10.1124/jpet.123.002032.
3
Reversal of morphine-induced respiratory depression with the µ-opioid receptor antagonist naloxonazine engenders excitation and instability of breathing.
Am J Physiol Lung Cell Mol Physiol. 2025 Jul 1;329(1):L97-L111. doi: 10.1152/ajplung.00045.2025. Epub 2025 May 14.
4
Reversal and Prevention of the Respiratory-Depressant Effects of Heroin by the Novel -Opioid Receptor Antagonist Methocinnamox in Rhesus Monkeys.
J Pharmacol Exp Ther. 2019 Feb;368(2):229-236. doi: 10.1124/jpet.118.253286. Epub 2018 Nov 21.
5
Methocinnamox Reverses and Prevents Fentanyl-Induced Ventilatory Depression in Rats.
J Pharmacol Exp Ther. 2021 Apr;377(1):29-38. doi: 10.1124/jpet.120.000387. Epub 2021 Jan 11.
6
Opioid Overdose: Limitations in Naloxone Reversal of Respiratory Depression and Prevention of Cardiac Arrest.
Anesthesiology. 2023 Sep 1;139(3):342-353. doi: 10.1097/ALN.0000000000004622.
7
Buprenorphine Pharmacodynamics: A Bridge to Understanding Buprenorphine Clinical Benefits.
Drugs. 2025 Feb;85(2):215-230. doi: 10.1007/s40265-024-02128-y. Epub 2025 Jan 28.
8
Searching for Synthetic Opioid Rescue Agents. 2: Identification of an Ultra-Potent Synthetic Opioid Rescue Agent.
J Med Chem. 2025 Jun 26;68(12):13057-13074. doi: 10.1021/acs.jmedchem.5c01108. Epub 2025 Jun 11.
9
Antinociceptive effects of fentanyl and nonopioid drugs in methocinnamox-treated rats.
Drug Alcohol Depend. 2024 Jul 1;260:111320. doi: 10.1016/j.drugalcdep.2024.111320. Epub 2024 Apr 29.
10
Time Course of Reversal of Fentanyl-Induced Respiratory Depression in Healthy Subjects by Intramuscular Nalmefene and Intramuscular and Intranasal Naloxone.
J Clin Pharmacol. 2025 Feb;65(2):206-216. doi: 10.1002/jcph.6132. Epub 2024 Sep 30.
本文引用的文献
1
Reversal of Opioid-Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone.
J Clin Pharmacol. 2024 Jul;64(7):828-839. doi: 10.1002/jcph.2421. Epub 2024 Mar 4.
2
Comparison of the -Opioid Receptor Antagonists Methocinnamox and Naloxone to Reverse and Prevent the Ventilatory Depressant Effects of Fentanyl, Carfentanil, 3-Methylfentanyl, and Heroin in Male Rats.
J Pharmacol Exp Ther. 2024 Sep 18;391(1):4-17. doi: 10.1124/jpet.123.002032.
3
Daily methocinnamox treatment dose-dependently attenuates fentanyl self-administration in rhesus monkeys.
Neuropharmacology. 2024 Feb 1;243:109777. doi: 10.1016/j.neuropharm.2023.109777. Epub 2023 Nov 8.
4
Pharmacokinetic Properties of an FDA-approved Intranasal Nalmefene Formulation for the Treatment of Opioid Overdose.
Clin Pharmacol Drug Dev. 2024 Jan;13(1):58-69. doi: 10.1002/cpdd.1312. Epub 2023 Jul 27.
5
Attenuation of the Positive-Reinforcing Effects of Ultra-Potent Fentanyl Analogs, Along with Those of Fentanyl and Heroin, During Daily Treatment with Methocinnamox in Rhesus Monkeys.
J Pharmacol Exp Ther. 2023 Mar;384(3):363-371. doi: 10.1124/jpet.122.001267. Epub 2022 Dec 27.
6
The Potential of Methocinnamox as a Future Treatment for Opioid Use Disorder: A Narrative Review.
Pharmacy (Basel). 2022 Apr 19;10(3):48. doi: 10.3390/pharmacy10030048.
7
Effects of Daily Methocinnamox Treatment on Fentanyl Self-Administration in Rhesus Monkeys.
J Pharmacol Exp Ther. 2022 Aug;382(2):181-187. doi: 10.1124/jpet.122.001233. Epub 2022 May 28.
8
Treatment of opioid overdose: current approaches and recent advances.
Psychopharmacology (Berl). 2022 Jul;239(7):2063-2081. doi: 10.1007/s00213-022-06125-5. Epub 2022 Apr 7.
9
Long-term antagonism and allosteric regulation of mu opioid receptors by the novel ligand, methocinnamox.
Pharmacol Res Perspect. 2021 Dec;9(6):e00887. doi: 10.1002/prp2.887.
10
The Birth of Naloxone: An Intellectual History of an Ambivalent Opioid.
Camb Q Healthc Ethics. 2021 Oct;30(4):637-650. doi: 10.1017/S0963180121000116.
Zotero 插件